STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] ABBOTT LABORATORIES Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

John G. Stratton, a director of Abbott Laboratories (ABT), had 293 stock-equivalent units credited on 09/30/2025 under a grantor trust that converts director fees into units that track Abbott share returns. The units are valued at $133.94 each in this filing and the reporting person’s total beneficial ownership after the transaction is reported as 12,663 shares or share equivalents. The filing explains these units are paid in cash generally at age 65 or upon retirement from the board and that the balance includes units from a dividend reinvestment feature. The Form 4 was signed by an attorney-in-fact on 10/02/2025.

Positive
  • Director compensation converted to stock-equivalents aligns pay with shareholder returns
  • Dividend reinvestment feature increased the balance of stock-equivalent units
Negative
  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Stratton John G

(Last) (First) (Middle)
100 ABBOTT PARK ROAD

(Street)
ABBOTT PARK IL 60064

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Equivalent Units (1) 09/30/2025 A 293 (1) (1) Common Shares 293 $133.94 12,663(2) D
Explanation of Responses:
1. Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.
2. Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.
/s/ John G. Stratton by Jessica H. Paik, Attorney-in-Fact 10/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did John G. Stratton report on the Form 4 for ABT?

He reported the crediting of 293 stock-equivalent units on 09/30/2025, bringing his total beneficial ownership to 12,663 share equivalents.

How were the 293 units acquired according to the filing?

The units were credited as director fees into a grantor trust that pays in cash at age 65 or upon board retirement; the filing lists the transaction code as an acquisition.

What price is shown for the stock-equivalent units?

The filing states a per-unit amount of $133.94 associated with the reported units.

When will the stock-equivalent units be paid out?

The filing specifies they are paid, in cash, generally at age 65 or upon retirement from the board.

Does the reported balance include dividends?

Yes. The filing explains the balance includes stock-equivalent units acquired pursuant to a dividend reinvestment feature.
Abbott Labs

NYSE:ABT

ABT Rankings

ABT Latest News

ABT Latest SEC Filings

ABT Stock Data

226.11B
1.73B
0.54%
80.8%
1.02%
Medical Devices
Pharmaceutical Preparations
Link
United States
ABBOTT PARK